Non-specific effects should be included in the full public health evaluation of maternal IIV. These findings are important for policymakers and community to improve immunisation.
Holland et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: